Aspirin is recommended in established atherosclerotic cardiovascular disease to lower the risk of adverse health outcomes. Yet findings from observational studies and post hoc analyses of trial data are discordant regarding the preferred dosage, and there are open questions about side effects. New research findings are summarized in a short video.
top of page
bottom of page